Cargando…
The benefits of more government interference in prescription drug pricing
• Price of prescription drugs reform has gained bipartisan support. • 25% of Americans find it difficult to afford necessary prescriptions. • Price caps do not hinder innovation, but rather are common-sense solutions. • Price caps mandate innovation be conducted in a fiscally responsible and moral w...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297769/ https://www.ncbi.nlm.nih.gov/pubmed/37383579 http://dx.doi.org/10.1016/j.hpopen.2022.100071 |
| _version_ | 1785063955911147520 |
|---|---|
| author | Houser, Ryan S. |
| author_facet | Houser, Ryan S. |
| author_sort | Houser, Ryan S. |
| collection | PubMed |
| description | • Price of prescription drugs reform has gained bipartisan support. • 25% of Americans find it difficult to afford necessary prescriptions. • Price caps do not hinder innovation, but rather are common-sense solutions. • Price caps mandate innovation be conducted in a fiscally responsible and moral way. |
| format | Online Article Text |
| id | pubmed-10297769 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102977692023-06-28 The benefits of more government interference in prescription drug pricing Houser, Ryan S. Health Policy Open Letters to the Editor • Price of prescription drugs reform has gained bipartisan support. • 25% of Americans find it difficult to afford necessary prescriptions. • Price caps do not hinder innovation, but rather are common-sense solutions. • Price caps mandate innovation be conducted in a fiscally responsible and moral way. Elsevier 2022-04-09 /pmc/articles/PMC10297769/ /pubmed/37383579 http://dx.doi.org/10.1016/j.hpopen.2022.100071 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Letters to the Editor Houser, Ryan S. The benefits of more government interference in prescription drug pricing |
| title | The benefits of more government interference in prescription drug pricing |
| title_full | The benefits of more government interference in prescription drug pricing |
| title_fullStr | The benefits of more government interference in prescription drug pricing |
| title_full_unstemmed | The benefits of more government interference in prescription drug pricing |
| title_short | The benefits of more government interference in prescription drug pricing |
| title_sort | benefits of more government interference in prescription drug pricing |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297769/ https://www.ncbi.nlm.nih.gov/pubmed/37383579 http://dx.doi.org/10.1016/j.hpopen.2022.100071 |
| work_keys_str_mv | AT houserryans thebenefitsofmoregovernmentinterferenceinprescriptiondrugpricing AT houserryans benefitsofmoregovernmentinterferenceinprescriptiondrugpricing |